NEJM Interviews cover image

NEJM Interview: Peter Ubel on strategies for protecting patients from high out-of-pocket costs for drugs with questionable benefits.

NEJM Interviews

00:00

Exploring Policies for Drug Price Regulation and Patient Cost Relief

This chapter examines potential federal policy measures to regulate new drug prices, emphasizing cost-effectiveness analysis akin to UK's system. It discusses Medicare's role in setting price thresholds and the bipartisan effort to tackle high medication costs impacting Americans.

Play episode from 04:34
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app